A M Magnuson1, D P Regan2, J K Fouts1, A D Booth1, S W Dow2, M T Foster1. 1. Department of Food Science and Human Nutrition, Colorado State University, Fort Collins, CO, 80523, USA. 2. Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO, 80523, USA.
Abstract
OBJECTIVES: The spatial proximity of adipose depots to secondary lymph nodes allows a unique relation between the two systems. Obesity, predominately visceral adiposity, links to numerous diseases; hence, we postulate that secondary lymphatics within this region contributes to disease risk. MATERIAL AND METHODS: Male C57BL/6 mice were fed standard CHOW (18% kcal fat) or Western diet (45% kcal fat) for 7 weeks. Visceral and subcutaneous lymph nodes and associated adipose depots they occupy were excised. Lymph node morphology and resident immune cell populations were characterized via histopathology, immunofluorescence and flow cytometry. Adipose tissue immune cell populations were also characterized. RESULTS: Obesity caused lymph node expansion, increased viable cell number and deviations in immune cell populations. These alterations were exclusive to visceral lymph nodes. Notably, pro-inflammatory antigen presenting cells and regulatory T cells increased in number in the visceral lymph node. Obesity, however, reduced T regulatory cells in visceral lymph nodes. The visceral adipose depot also had greater reactivity towards HFD than subcutaneous, with a greater percent of macrophages, dendritic and CD8+ T cells. Immune cell number, in both the visceral and subcutaneous, however decreased as adipose depots enlarged. CONCLUSION: Overall, HFD has a greater influence on visceral cavity than the subcutaneous. In the visceral lymph node, but not subcutaneous, HFD-induced obesity decreased cell populations that suppressed immune function while increasing those that regulate/activate immune response.
OBJECTIVES: The spatial proximity of adipose depots to secondary lymph nodes allows a unique relation between the two systems. Obesity, predominately visceral adiposity, links to numerous diseases; hence, we postulate that secondary lymphatics within this region contributes to disease risk. MATERIAL AND METHODS: Male C57BL/6 mice were fed standard CHOW (18% kcal fat) or Western diet (45% kcal fat) for 7 weeks. Visceral and subcutaneous lymph nodes and associated adipose depots they occupy were excised. Lymph node morphology and resident immune cell populations were characterized via histopathology, immunofluorescence and flow cytometry. Adipose tissue immune cell populations were also characterized. RESULTS:Obesity caused lymph node expansion, increased viable cell number and deviations in immune cell populations. These alterations were exclusive to visceral lymph nodes. Notably, pro-inflammatory antigen presenting cells and regulatory T cells increased in number in the visceral lymph node. Obesity, however, reduced T regulatory cells in visceral lymph nodes. The visceral adipose depot also had greater reactivity towards HFD than subcutaneous, with a greater percent of macrophages, dendritic and CD8+ T cells. Immune cell number, in both the visceral and subcutaneous, however decreased as adipose depots enlarged. CONCLUSION: Overall, HFD has a greater influence on visceral cavity than the subcutaneous. In the visceral lymph node, but not subcutaneous, HFD-induced obesity decreased cell populations that suppressed immune function while increasing those that regulate/activate immune response.
Authors: Daniel A Winer; Shawn Winer; Lei Shen; Persis P Wadia; Jason Yantha; Geoffrey Paltser; Hubert Tsui; Ping Wu; Matthew G Davidson; Michael N Alonso; Hwei X Leong; Alec Glassford; Maria Caimol; Justin A Kenkel; Thomas F Tedder; Tracey McLaughlin; David B Miklos; H-Michael Dosch; Edgar G Engleman Journal: Nat Med Date: 2011-04-17 Impact factor: 53.440
Authors: Marieke B Snijder; Jacqueline M Dekker; Marjolein Visser; Lex M Bouter; Coen D A Stehouwer; Piet J Kostense; John S Yudkin; Robert J Heine; Giel Nijpels; Jacob C Seidell Journal: Am J Clin Nutr Date: 2003-05 Impact factor: 7.045
Authors: Calum C Bain; Alberto Bravo-Blas; Charlotte L Scott; Elisa Gomez Perdiguero; Frederic Geissmann; Sandrine Henri; Bernard Malissen; Lisa C Osborne; David Artis; Allan McI Mowat Journal: Nat Immunol Date: 2014-08-24 Impact factor: 25.606
Authors: María del Mar Romero; José Antonio Fernández-López; Montserrat Esteve; Marià Alemany Journal: Cardiovasc Diabetol Date: 2009-07-30 Impact factor: 9.951
Authors: Aaron M Magnuson; Daniel P Regan; Andrea D Booth; Josephine K Fouts; Claudia M Solt; Jessica L Hill; Steve W Dow; Michelle T Foster Journal: Eur J Nutr Date: 2019-06-04 Impact factor: 5.614
Authors: Paulius V Kuprys; Hidekazu Tsukamoto; Bin Gao; Lin Jia; Jacob McGowan; Craig M Coopersmith; Maria Camargo Moreno; Holly Hulsebus; Avtar S Meena; Flavia M Souza-Smith; Philip Roper; Michelle T Foster; S Vamsee Raju; S Alex Marshall; Mayumi Fujita; Brenda J Curtis; Todd A Wyatt; Pranoti Mandrekar; Elizabeth J Kovacs; Mashkoor A Choudhry Journal: Alcohol Date: 2018-08-24 Impact factor: 2.405